Answers are grounded in this paper and cite their sources.
Background: Myocardial infarction (MI), sometimes referred to as a heart attack, is a leading cause of mortality on a global scale. This medical ailment is sometimes referred to as a myocardial infarction. To mitigate the issue, it is essential to promptly conduct diagnostic examinations and start therapy for lipid abnormalities. Objectives: The aim of this study is to provide a comprehensive description of the variables associated with elevated low-density lipoprotein cholesterol (LDL-c) levels and to evaluate the treatment results of rosuvastatin in patients diagnosed with acute myocardial infarction at Tra Vinh General Hospital throughout the period of 2021-2022. Materials and methods: The objective of each of these experiments was to ascertain the attributes associated with high lowdensity lipoprotein cholesterol (LDL-c). Both of these trials were designed to be carried out on individuals who had a previous record of increased levels of low-density lipoprotein cholesterol (LDL-c). Enumerated here are the many procedures and components: A total of 199 individuals were included in a cross-sectional research, all of whom presented with both early-onset acute myocardial infarction and dyslipidemia. The aforementioned people originated from four separate familial lineages characterized by a historical prevalence of the aforementioned ailment. The research described in this study was conducted inside the Department of Cardiology-Geriatrics, with no intervention being necessary. Results: The findings indicate that 52.5% of those who had LDL-c level assessments demonstrated ideal levels, while 24.2% exhibited levels that were somewhat near to the normal range. Additionally, 3.0% of the participants displayed LDL-c levels that significantly above the normal range. Following the conclusion of the therapeutic intervention, the LDL-c concentrations of the participants exhibited a notable reduction, with an average value of 1.10±0.61mmol/L. Furthermore, a significant proportion of the participants, namely 63.8%, achieved the predetermined control objective. Conclusions: The administration of the rosuvastatin regimen has been shown to be a highly successful approach in attaining the necessary elevation of LDL-c levels, hence playing a crucial role in the management and prevention of many medical conditions among patients and their families.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: